Uta Kemmerich-Keil

Uta Kemmerich-Keil

Shareholder representative
Darmstadt, Germany
Member since: Mai 2022

Personal Information

Date of Birth: 27 December 1966
Place  of Birth:     Attendorn, Germany
Nationality: German


MSc – Master of Economics, Albert-Ludwigs-University Freiburg, Germany
MA – Master of Arts in Roman Philology, Albert-Ludwigs-University Freiburg, Germany
BA – Licence Franco-Allemande, Nouvelle Sorbonne Paris III, France


2018 - 2020 Procter & Gamble (Geneva, Switzerland),
CEO Personal Healthcare Internationa
1999 - 2018

Merck KGaA (Darmstadtand Reinbek, Germany)

  • CEO & President of Merck Consumer Health division
  • CEO Allergopharma GmbH & Co KG and Head of Global Business Unit Allergy
  • Executive Vice President Corporate Finance
  • Senior Vice President Corporate M&A and Merger Integration
  • Vice President Financial Controlling Business Sector Pharmaceuticals
  • Director Acquisitions Controlling
1996 - 1999

Hoechst AG (Frankfurt, Germany)
Senior Financial Auditor/Financial Auditor in Corporate Internal Auditing

1993 - 1995 Albert-Ludwigs-University (Freiburg, Germany)
Assistant Professor at Department of Roman Philology

Membership in Supervisory Boards and Comparable Controlling Bodies

  • Klosterfrau AG, Zürich, Board Member
  • Affimed NV, Heidelberg, NASDAQ listed, Board Member + Chair Audit Committee
  • Karo Pharma AB, Sweden, listed at Nasdaq Stockholm, Board Member + Audit Committee
  • Röchling SE & CO KG, Mannheim, Board Member + member of Medical Board
  • Schott AG, Mainz, Board Member